Intrinsic Value of S&P & Nasdaq Contact Us

Inventiva S.A. IVA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • FR • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.80
+186.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Inventiva S.A. (IVA) has a negative trailing P/E of -8.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 17.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -12.48%, forward earnings yield 5.83%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+186.8%).
  • Forward P/E 17.1 — analysts expect a return to profitability with estimated EPS of $0.32 for FY2030.
  • Trailing Earnings Yield -12.48% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 5.83% as earnings recover.
  • Analyst consensus target $15.80 (+186.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 45/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
45/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — IVA

Valuation Multiples
P/E (TTM)-8.0
Forward P/E17.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio-303.68
P/S Ratio138.19
EV/EBITDA-2.3
Per Share Data
EPS (TTM)$-0.56
Forward EPS (Est.)$0.32
Book Value / Share$-0.01
Revenue / Share$0.01
FCF / Share$-0.22
Yields & Fair Value
Earnings Yield-12.48%
Forward Earnings Yield5.83%
Dividend Yield0.00%
Analyst Target$15.80 (+186.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -28.4 0.58 5.59 21.16 -
2017 -10.1 -0.07 2.71 26.60 -
2018 -7.2 -0.15 3.90 75.19 -
2019 -9.3 0.42 6.80 40.22 -
2020 -12.0 0.53 3.61 1,080.34 -
2021 -9.5 -0.34 5.29 112.19 -
2022 -3.2 -1.01 3.80 14.18 -
2023 -1.7 -0.02 -5.79 10.61 -
2024 -0.6 -0.01 -1.01 11.68 -
2025 -2.2 0.04 0.00 171.69 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-0.88 $4.87M $-8.82M -181%
2016 $-0.45 $9.45M $-7.05M -74.6%
2017 $-1.11 $6.52M $-17.23M -264.2%
2018 $-1.64 $3.2M $-33.62M -1051.5%
2019 $-1.28 $7M $-30.22M -431.9%
2020 $-0.93 $372K $-31.62M -8500.8%
2021 $-1.27 $4.19M $-49.64M -1183.5%
2022 $-1.31 $12.18M $-54.27M -445.6%
2023 $-2.43 $17.48M $-110.43M -631.8%
2024 $-3.54 $9.2M $-184.21M -2002.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.68 $-1.57 – $-0.39 $2.84M $1.86M – $3.83M 4
2027 $-0.68 $-1.67 – $-0.32 $25.51M $12.36M – $38.63M 5
2028 $-0.56 $-0.70 – $-0.42 $97.97M $63.95M – $131.91M 2
2029 $-0.11 $-0.16 – $-0.06 $262.19M $171.15M – $353M 1
2030 $0.32 $0.32 – $0.32 $595.9M $595.9M – $595.9M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message